🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
This study is to define the pharmacokinetics and to evaluate the safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07-01
Trial ID
NCT00960258
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
To measure the level of circulating tumor DNA (ctDNA) in the blood of color...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05-17
Trial ID
NCT05900648
Treatments Being Tested
Trial evaluating the efficacy of regorafenib combined with irinotecan compa...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest-Paul Papin
Start Date
2019-02-07
Trial ID
NCT03722108
Treatments Being Tested
The aim of the project is to improve treatment outcomes in patients with pr...
Status
Completed
Location
the Institute of Mother and Child
Start Date
2022-04-28
Trial ID
NCT05395741
Treatments Being Tested
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
The study aims to evaluate use of regorafenib in clinical practice in Hunga...
Status
Completed
Location
Multiple Locations
Start Date
2016-07-01
Trial ID
NCT02656524
Treatments Being Tested